[Orientations and present day possibilities for use of anti-HIV drugs]. 1996

V Amato Neto, and J Pasternak, and V S Amato
Departamento de Doenças Infecciosas e Parasitárias, Universidade de São Paulo, SP.

UI MeSH Term Description Entries
D006266 Health Education Education that increases the awareness and favorably influences the attitudes and knowledge relating to the improvement of health on a personal or community basis. Community Health Education,Education, Health,Education, Community Health,Health Education, Community
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human

Related Publications

V Amato Neto, and J Pasternak, and V S Amato
June 1963, Il Valsalva,
V Amato Neto, and J Pasternak, and V S Amato
December 1954, Il Policlinico. Sezione pratica,
V Amato Neto, and J Pasternak, and V S Amato
June 1978, Wiadomosci lekarskie (Warsaw, Poland : 1960),
V Amato Neto, and J Pasternak, and V S Amato
November 1959, Bollettino chimico farmaceutico,
V Amato Neto, and J Pasternak, and V S Amato
January 1994, Klinicheskaia meditsina,
V Amato Neto, and J Pasternak, and V S Amato
March 1964, Der Internist,
V Amato Neto, and J Pasternak, and V S Amato
May 1962, La Presse medicale,
V Amato Neto, and J Pasternak, and V S Amato
June 1955, Concours medical,
V Amato Neto, and J Pasternak, and V S Amato
May 1950, Minerva medica,
V Amato Neto, and J Pasternak, and V S Amato
December 2009, Therapeutische Umschau. Revue therapeutique,
Copied contents to your clipboard!